Moderna Coronavirus Vaccine Approved in Europe

1 min read

Less than a month after winning emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its coronavirus vaccine, Moderna (NASDAQ: MRNA) has scored another major regulatory nod.

On Wednesday, the company announced that the European Commission — the executive arm of the 27-country European Union (EU) — granted conditional marketing authorization (CMA) for the company’s mRNA-1273.

Moderna’s vaccine is now authorized for use against the coronavirus in four jurisdictions. Besides the EU and the U.S., it has also been cleared in Canada and Israel.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

Why Northern Genesis Acquisition (Lion Electric) Stock Is Up Today

Next Story

The U.S. May Include Alibaba, Tencent in China Stock Ban

Latest from Blog